These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374 [TBL] [Abstract][Full Text] [Related]
24. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides. Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717 [TBL] [Abstract][Full Text] [Related]
25. Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow. Khanna A; Steptoe RJ; Antonysamy MA; Li W; Thomson AW Transplantation; 1998 Feb; 65(4):479-85. PubMed ID: 9500620 [TBL] [Abstract][Full Text] [Related]
26. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization. Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Fung JJ Immunology; 1995 May; 85(1):82-7. PubMed ID: 7635525 [TBL] [Abstract][Full Text] [Related]
27. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice. Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596 [TBL] [Abstract][Full Text] [Related]
28. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages. Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993 [TBL] [Abstract][Full Text] [Related]
29. Thyroid allograft immunogenicity is reduced after a period in organ culture. Lafferty KJ; Cooley MA; Woolnough J; Walker KZ Science; 1975 Apr; 188(4185):259-61. PubMed ID: 1118726 [TBL] [Abstract][Full Text] [Related]
30. Influence of histocompatibility and transplant site on survival. Perloff LJ; Utiger RD; Alavi A; Barker CF Ann Surg; 1978 Aug; 188(2):186-96. PubMed ID: 686886 [TBL] [Abstract][Full Text] [Related]
31. Thyroid graft rejection between C57BL/6 and H-2Kb mutant mice. Differences in the immunogenic expression of the mutated molecule on thyroids of six different mutants. Isakov N; Bach FH Transplantation; 1983 Nov; 36(5):571-7. PubMed ID: 6356521 [TBL] [Abstract][Full Text] [Related]
33. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice. Margenthaler JA; Landeros K; Kataoka M; Flye MW Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472 [TBL] [Abstract][Full Text] [Related]
34. Prolongation of in vivo mouse islet allograft survival by modulation of MHC class I antigen. Osorio RW; Ascher NL; Stock PG Transplantation; 1994 Mar; 57(6):783-8. PubMed ID: 8154021 [TBL] [Abstract][Full Text] [Related]
35. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244 [TBL] [Abstract][Full Text] [Related]
37. Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells. Isakov N; Segal S Immunobiology; 1983 Dec; 165(5):485-99. PubMed ID: 6363278 [TBL] [Abstract][Full Text] [Related]
38. Genetic control of variability in responses to class-I-antigen-disparate thyroid grafts. Isakov N; Bach FH Transplantation; 1985 Mar; 39(3):303-9. PubMed ID: 3919481 [TBL] [Abstract][Full Text] [Related]
39. Organ donor or graft pretreatment to prolong allograft survival: lessons learned in the murine model. Pollak R; Blanchard JM Transplantation; 2000 Jun; 69(11):2432-9. PubMed ID: 10868654 [TBL] [Abstract][Full Text] [Related]
40. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]